Skip Navigation
Polsinelli's logo
  • Our People
  • Our Capabilities
  • Our Firm
    • About Us
    • Alumni Network
    • Careers
    • Insights
      • News
      • Events
      • Publications
      • Blogs & Podcasts
    • Offices & Locations
    • Our Diverse Culture

Biotechnology & Life Sciences Patent Prosecution

  • Overview
  • Matters
  • People
  • News
  • Publications
  • Events

News

March 05, 2026 Deals & Cases
Polsinelli Advises SpyGlass Pharma on Intellectual Property Matters in Initial Public Offering
February 27, 2026 Awards & Recognitions
Polsinelli’s Intellectual Property Practice Earns Multiple Juristat Patent Rankings
October 22, 2024 News
Polsinelli Continues Life Sciences Growth With Experienced Hatch-Waxman and Biologics Attorney Stacie Ropka
September 12, 2024 News
Polsinelli Grows Patent Roster in St. Louis with Former Life Sciences In-House Counsel Benjamin J. Sodey
Firm Highlights
Slide 1 of 6
  • News
    Polsinelli Advises Americana Partners on Acquisition of NRT Consulting
    Polsinelli recently represented Americana Partners (Americana), a Houston-based wealth management firm, in its acquisition of NRT Consulting, a bespoke and full-service financial consulting and accounting firm.
    Read more
  • News
    Polsinelli Secures Dismissal of Data Breach Class Action for Delta Health
    Polsinelli recently secured a significant win for firm client Delta County Memorial Hospital District (Delta Health), obtaining dismissal of a putative data breach class action in the District Court for Delta County, Colorado.
    Read more
  • Event
    Polsinelli Pulse Series: Shelf Space – Strategies for Dominating the CPG Marketplace
    Join Polsinelli as we speak with investors in, and founders of, your favorite CPG brands, to learn what they’ve done right, what they’ve done wrong, and what they’re still trying to figure out.
    Read more
  • Publication
    The Politics of AI Regulation: Federal Government v. the States
    On December 11, 2025, President Trump signed Executive Order 14365, “Ensuring a National Policy Framework for Artificial Intelligence.” 
    Read more
  • Blog
    Where Identity Meets Precedent: The EEOC Addresses Bathroom and Locker Room Access Under Title VII
    Read more
  • Publication
    Not Joking Around: FDA Offers Additional Clarification on Compounded GLP-1 Policy in April Fool’s Day Announcement
    FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications.
    Read more
Follow us on LinkedInFollow us on Instagram
© 2026 Polsinelli. Attorney Advertising.
Prior results do not guarantee a similar outcome.
Contact UsSubscribeAlumni NetworkCollaborate PolsinelliClient Payment PortalDisclaimerCookie PreferencesPrivacy Notice